<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487967/" ref="ordinalpos=999&amp;ncbi_uid=4353695&amp;link_uid=PMC3487967" image-link="/pmc/articles/PMC3487967/figure/F8/" class="imagepopup">Figure 8.  From: Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: Incorporating EGFR <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> and angiogenesis. </a></div><br /><div class="p4l_captionBody"><b>Sensitivity analysis of EGFR signaling pathway.</b> The result shows that the migration potential of brain cancer cells is most sensitive to the initial concentration of EGFR (X2) and TGFÎ± (X1). The result also shows us forward kinetic rates (k1, k2, k3, k5) are more important in the system and demonstrate that the developed intracellular pathway system is robust.</div></div>